The Fight Against Disease Mongering: Generating Knowledge for Action
Author Information
Author(s): Ray Moynihan, David Henry
Primary Institution: University of Newcastle, Newcastle, New South Wales, Australia
Hypothesis
We need better research to identify, understand, and combat the threat to human health from the corporate-sponsored selling of sickness.
Conclusion
Combating disease mongering may improve the personal health of individuals, as well as the financial health of public and private insurers.
Supporting Evidence
- Disease mongering turns healthy people into patients and wastes resources.
- Pharmaceutical companies often promote conditions to expand their markets.
- Many health problems are framed as widespread and treatable with pills.
Takeaway
Some companies try to convince healthy people that they are sick so they can sell them medicine, which can be harmful and waste money.
Methodology
The views in this article are based on observations and interpretation informed by interviews with stakeholders and other more journalistic research methods.
Potential Biases
Different stakeholders may have conflicting motives regarding disease mongering, complicating the understanding of the phenomenon.
Limitations
The article does not employ deeper academic investigation that uses qualitative and quantitative research techniques.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website